During the recent session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.56 million, with the beta value of the company hitting -0.26. At the last
Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 1.02 million during the last session, with the company’s beta value hitting -0.25. At the close of
Lyell Immunopharma Inc (NASDAQ:LYEL) has a beta value of -0.17 and has seen 1.13 million shares traded in the last trading session. The company, currently
In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 0.72 million shares changing hands with its beta currently measuring -0.23. Company’s recent per share price
During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.62 million, with the beta value of the company hitting -0.34. At the end
In the last trading session, 1.29 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.29. Most recently the company’s
Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 2.31 million during the last session, with the company’s beta value hitting -0.22. At the close of
In the last trading session, 1.02 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.31. With the company’s per share
In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 0.45 million shares changing hands with its beta currently measuring -0.55. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
